Background and Objectives Continuous perineural femoral analgesia has been reported to reduce numeric rating pain scores (NRS, scale 0-10) after anterior cruciate ligament reconstruction (ACLR). In the current study, we determined rebound pain scores in autograft ACLR outpatients after nerve block analgesia resolved.
Methods After standardized spinal anesthesia and perioperative multimodal analgesia, patients received a femoral perineural catheter and 50 hours of saline or levobupivacaine. All patients received levobupivacaine (30 mL of 0.25% as a bolus) before the infusion. Patients completed a pain diary for 6 days, indicating serial NRS scores and perceptions of when nerve block analgesia resolved. Block duration and rebound pain scores were computed.
Results Data from 84 participants' pain diaries were analyzed. Patients receiving saline infusion reported mean nerve block duration of 37 hours versus 59 hours for patients receiving the levobupivacaine infusion (P < .001). Mean rebound pain scores increased by 2.0 (95% confidence interval, 1.6-2.4). Based on the computations used to derive block duration and rebound pain scores, each hour of additional block duration was predictive of a 0.03-unit reduction in rebound pain scores.
Conclusions In an anesthesia care protocol consisting of spinal anesthesia and multimodal analgesia during and after autograft ACL reconstruction, approximately 33 hours of additional nerve block duration were required to reduce rebound pain scores by one unit. Further study is required to determine rebound pain score differences when other local anesthetics and anesthetic/analgesic plans are being used and when other surgeries are being performed.
- Acute pain
- Anterior cruciate ligament reconstruction
- Continuous nerve block
- Femoral nerve block
- Spinal anesthesia
- Rebound pain
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Supported by the National Institutes of Health/National Institute of Arthritis, Musculoskeletal, and Skin Diseases grant K23 AR47631, Bethesda, MD (B.A.W.), and International Anesthesia Research Society Clinical Scholar Research Award (2001), Cleveland, OH (B.A.W.). Additional support from the University of Pittsburgh Department of Anesthesiology. Nerve stimulation needles (Prolong PL-50) were provided by Spinal Specialties, Inc., San Antonio, TX; Life-Tech, Inc., Stafford, TX; and I-Flow Corporation, Lake Forest, CA. Elastomeric nerve block infusion devices were provided by McKinley Medical, Wheat Ridge, CO. Patient samples of rofecoxib were provided by Merck & Co., Inc., Whitehouse Station, NJ.
Reprints are not available.